Severe Diseases / en We Are Prioritising Innovation in Healthcare /innovation/magazine/detail/article/we-are-prioritising-innovation-in-healthcare <span>We Are Prioritising Innovation in Healthcare</span> <div class="field field--name-field-newsroom-author-title field--type-string field--label-above field__items"> Rose Snipes, Development Solutions </div> <span><span lang about="/user/8781" typeof="schema:Person" property="schema:name" datatype content="Vlastimil.Vanco@ucb.com">Vanco Vlastimi…</span></span> <span><time datetime="2023-07-12T15:02:50+02:00" title="Wednesday 12 July 2023 - 15:02">Wed 12/07/2023 - 15:02</time> </span> <div class="field field--name-field-newsroom-author-image field--type-entity-reference field--label-above field__items"> <article class="media media--type-image media--view-mode-default"> <div class="field field--name-image field--type-image field--label-hidden field__items"> <img loading="lazy" src="/sites/default/files/styles/ucb_header_image/public/2023-07/Rose%20Snipes.jpg.webp?itok=1IWaEXVt" width="100" height="100" typeof="foaf:Image"> </div> </article> </div> <div class="field field--name-field-newsroom-content field--type-text-long field--label-above field__items"> <p><br> ½ðºÌÓéÀÖ³Ç's mission to improve the health and well-being of people living with severe diseases is driven by a commitment to innovation in healthcare. As a global biopharmaceutical company, we are fully committed to pushing boundaries with purpose and carefully considering the needs of patients, thereby driving innovation in crucial areas.<br> <br> This commitment to innovation drives every aspect of the organization’s work, from the discovery and development of new medicines to their delivery to patients.<br> &nbsp;</p> <h3>Improving Lives of Patients with Severe Diseases</h3> <p>One key aspect of innovation at ½ðºÌÓéÀÖ³Ç is the focus on understanding the reality in which patients live. To better understand patients' needs and experiences, we need to continuously look to find new ways of connecting with them both inside and outside the clinic.&nbsp;<br> <br> Engaging with patients throughout the drug development process also helps identify unmet medical needs, guide clinical trial design, and support the regulatory approval process.<br> &nbsp;</p> <h3>Patient Involvement is Key</h3> <p>Ultimately, everyone at ½ðºÌÓéÀÖ³Ç believes that patient involvement can help ensure that new drugs and treatments meet the needs of the patients they are intended to help. Our aim is to create medicines that not only treat their diseases but also improve the lives of patients.<br> &nbsp;</p> <h3>½ðºÌÓéÀֳǒs Innovative Approach</h3> <p>At ½ðºÌÓéÀÖ³Ç, innovation in healthcare is not limited to the development of new drugs. It also extends to the way they deliver these drugs to patients. This includes exploring new technologies and approaches to drug delivery to ensure that patients receive the most effective and convenient treatment possible.<br> &nbsp;</p> <h3>½ðºÌÓéÀֳǒs Commitment to Innovation</h3> <p>½ðºÌÓéÀÖ³Ç's commitment to innovation in healthcare is driven by our passion for improving the lives of patients. We understand that every patient is unique, and that their needs and experiences must be considered to develop truly innovative solutions. I’m proud to be a part of this collaborative strategy, that involves patients, healthcare professionals, and researchers all working together to develop new treatments and approaches to care.<br> <br> To learn more about how innovation drives everything we do visit&nbsp;<a href="/our-science/Innovation-is">Innovation is | ½ðºÌÓéÀÖ³Ç</a><br> &nbsp;</p> </div> <div class="field field--name-field-newsroom-category field--type-entity-reference field--label-above field__items"> <a href="/taxonomy/term/1910" hreflang="en">innovation</a> </div> <div class="field field--name-field-newsroom-tags field--type-entity-reference field--label-above field__items"> <a href="/taxonomy/term/1226" hreflang="en">Patients</a> <a href="/taxonomy/term/1279" hreflang="en">Innovation</a> <a href="/taxonomy/term/10412" hreflang="en">Severe Diseases</a> <a href="/taxonomy/term/10313" hreflang="en">Innovators</a> <a href="/taxonomy/term/10413" hreflang="en">Patient involvement</a> </div> <div> <div class="comments-wrapper"> <div class="comment-area"> <h2 class="red">Leave a Comment</h2> <drupal-render-placeholder callback="comment.lazy_builders:renderForm" arguments="0=node&amp;1=14847&amp;2=field_newsroom_askexpert&amp;3=ask_expert" token="lrL3R2F5otJ9fnu1NS5pnYV_bEGn0gNYcUZreBg1Ryc"></drupal-render-placeholder> <span class="toggle-form js-toggle-form"></span> </div> </div> </div> <span class="a2a_kit a2a_kit_size_16 addtoany_list" data-a2a-url="/innovation/magazine/detail/article/we-are-prioritising-innovation-in-healthcare" data-a2a-title="We Are Prioritising Innovation in Healthcare"><a class="a2a_dd addtoany_share" href="https://www.addtoany.com/share#url=https%3A%2F%2Fwww.ucb.com%2Finnovation%2Fmagazine%2Fdetail%2Farticle%2Fwe-are-prioritising-innovation-in-healthcare&amp;title=We%20Are%20Prioritising%20Innovation%20in%20Healthcare"></a><a class="a2a_button a2a_button_facebook"><img src="/themes/custom/ucb_premier/images/a2a/facebook-icon.svg" width="16" height="16" border="0" alt="linkedin"></a><a class="a2a_button a2a_button_linkedin"><img src="/themes/custom/ucb_premier/images/a2a/linkedin-icon.svg" width="16" height="16" border="0" alt="linkedin"></a><a class="a2a_button a2a_button_twitter"><img src="/themes/custom/ucb_premier/images/a2a/twitter-icon.svg" width="16" height="16" border="0" alt="twitter"></a></span> <div class="field field--name-field-like field--type-likes-dislikes field--label-above field__items"> <div class="like_dislike"> <div class="like"> <a rel="nofollow" class="use-ajax" href="/like-dislike/like/eyJlbnRpdHlfdHlwZSI6Im5vZGUiLCJlbnRpdHlfaWQiOiIxNDg0NyIsImZpZWxkX25hbWUiOiJmaWVsZF9saWtlIiwibGlrZXMiOiI0NDAiLCJkaXNsaWtlcyI6Ii01MSJ9"></a> <span class="like-14847"> 440 Likes </span> </div> </div> <div id="like_dislike_status"></div> </div> Wed, 12 Jul 2023 13:02:50 +0000 Vanco Vlastimil (½ðºÌÓéÀÖ³Ç S.A.) 14847 at